DOWNLOADS (for participants only, password required)
POWERPOINT PRESENTATIONS 
ABSTRACTS & BIO ¦ WORKING GROUP SESSIONS INFORMATION
ARTICLES FOR WGS-1 ¦ ARTICLES FOR WGS-2 ¦ ARTICLES FOR WGS-3 ¦ ARTICLES FOR WGS-4
THE HUMAN BODY AS A SOURCE FOR THERAPEUTICS :
Ethical , Medical and Legal implications
REGISTRATION ONLY OPEN FOR THE SYMPOSIUM
FULL SCHEDULE
The 2009 Brocher Summer School will focus on the “Human Body as a Source for Therapeutics”. It will explore key issues in development of new therapeutics and related implications for the Human being and its body. A substantive focus will be given on the following topics :
· The use of parts of the Human body in medicine
· The history of the first transplants
· Legal principles and ethical issues related to the medical use of parts of the human body
· Infertility and Assisted Reproduction, Status of the embryo, Comparative analysis of public policy, controversies
· The Eurotransplant program, Living donors issues
· Predictive medicine, medical aspects, Insurance & Predictive medicine : the Ethical and Economical aspects
· Biobanks, medical & ethical issues, legal principles
· Symposium on stem cells research
Morning and Afternoon lectures
Ø Interdisciplinary approach
Ø Internationally-renowned professors
Ø Participation of high-level experts from the WHO
Ø Daily class discussions
Afternoon workshops
Ø In-depth and small-group study of selected issues addressed in morning and afternoon lectures
Symposium “From Promise to Practice: A new epoch for Stem Cell Research “
Ø Open to an international attendance.
Closing Roundtable on the Human Body as a source for therapeutics
MORNING
Chair : Vincent Barras
Professor at the Faculty of Biology and Medicine, University Institute of the History of Medicine and Public Health,
The use of Human Body in medicines
Christian Bonah
Historian and Doctor –
The history of the first Transplants
Susan E. Lederer
Chair of the Dpt of Medical History and Bioethics,
Followed by a discussion
AFTERNOON
Chair : Philippe Ducor
Director of the Interdisciplinary Master in Life Sciences and Law, University of
Legal principles and their categorization
Olivier Guillod
Director of the Institute for Medical Law, University of Neuchâtel (
Legal and Ethical issues
Trudo Lemmens
Professor, Faculty of Law and Medicine, University of
Working group sessions
TUESDAY 1st SEPTEMBER
MORNING
Chair : Dr Sheryl Vanderpoels
WHO, Medical Officer,
Infertility and Assisted Reproduction : medical introduction
Yvon Englert
Head of dept of Gynaecology and Obstetrics,
Status of the Embryo
Alex Mauron
Professor of Bioethics, Medical Faculty,
Followed by a discussion
AFTERNOON
Chair : Yvon Englert
Professor and Chief of Gynaecology and Obstetrics,
Assisted Reproduction : Comparative analysis of public policy
Frédéric Varone
Professor at the Economic and Social Sciences,
Controversy on : “Should multiple deliveries be considered as success?”
Allan Templeton
Professor of Obstetrics and Gynaecology, University of
René Frydman
Professor, Faculty of Medicine, University Paris XI and Head of the Department of Gynecology and Obstetrics of Antoine Beclere Hospital, Director of Research Unit on Reproductive medecine
Working group sessions
WEDNESDAY 2nd SEPTEMBER
MORNING
Chair : Philippe Ducor,
Director of the Interdisciplinary Master in Life Sciences and Law, University of
The Eurotransplant program
Frans Claas
Member of the Eurotransplant,
Living donor issues
Pierre-Yves Martin
Professor and Chairman, Dpt of Nephrology, University of
Followed by a discussion
WHO – Brief introduction to the objectives of the Ethics and Health Unit
Dr Marie Charlotte Bouësseau
Ethics and Health Unit, WHO,
THURSDAY 3rd SEPTEMBER
MORNING
Chair : Anne Cambon-Thomsen
Chair of the INSERM Unity 558, Geneticist,
Predictive medicine: Medical introduction
Stylianos Antonarakis
Professor and Chairman, Dpt of Genetic Medicine and Development,
Insurance & predictive medicine: the Ethical and economical aspects
Michael Hoy
Professor of Economics,
THURSDAY 3rd SEPTEMBER
AFTERNOON
Chair : Jan-Helge Solbakk
Professor, Section for Medical Ethics, Faculty of Medicine, University of
Biobanks - Medical and Legal Issues
Anne Cambon-Thomsen
Chair of the INSERM Unity 558, Geneticist,
Biobanks - Legal Principles
Dr Jane Kaye
The
Followed by a discussion
Working group sessions
FRIDAY 4th SEPTEMBER
SYMPOSIUM “From Promise to Practice: A new Epoch for Stem Cell Research”
MORNING SESSION : Medical and Ethical Implications
Stem Cells in the Clinic
Christopher Thomas Scott
Director, Stanford University Program on Stem Cells in Society
The Rise of Stem Cell Tourism
Timothy Caulfield
Director of Health Law, University of Alberta
The Embryonic Dilemma : Which disease, how safe?
Outi Hovatta
Professor of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institute
Roundtable Discussion
AFTERNOON SESSION : Political and Legal Perspectives
A Parliamentarian’s Perspective : Lawmaking in biology’s newest frontier
Senator Kay Patterson
Former Federal Australian Health Minister, Vice Chancellor’s Professional Fellow, University of Monash
A Fractured Landscape of Stem Cell Patents : Who owns what?
Aurora Plomer
Chair in Law and Bioethics, Director of SIBLE, School of Law, University of Sheffield
The State of the Stem Cell Industry
Paul Martin
Reader in Science and Technology Studies, Deputy Director, University of Nottingham
Roundtable Discussion
Concluding remarks
SATURDAY 5th SEPTEMBER
ROUNDTABLE
BSS Participants &
P. Ducor, Y. Englert, R. Gurny, A. Mauron, L. Scapozza.
Fondation Brocher l Route d’Hermance 471 - CP 70 CH - 1248 Hermance Tél. + 41 22 751 93 95 | F. + 41 22 751 93 91 | Email : |
eBusiness by |